The Economic Times News

Gujarat Kidney and Super Specialty IPO Day 1: Issue subscribed 90%; GMP, price band and key details

The Gujarat Kidney and Super Specialty IPO received a strong response on its opening day, with 90% subscription led by robust retail participation. While grey market signals point to a steady listing, analysts have flagged valuation concerns and advised caution given the companys aggressive expansion plans and premium pricing.